During the past decade, Instytut Kardiologii conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 12 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instytut Kardiologii" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Edwards Lifesciences" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Biotronik, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Kardiologii" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "SEAFOODplus" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Instytut Kardiologii" are "Coronary Artery Disease" (7 trials), "Angina Pectoris" (2 trials), "Aortic Valve Stenosis" (2 trials), "Cardiovascular Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Instytut Kardiologii" in a lesser frequency.

Most popular intervention types in "Instytut Kardiologii" are "Drug" (10 trials), "Device" (4 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ranolazine" (2 trials), "bococizumab (PF-04950615)" (2 trials), "mavacamten" (2 trials) and "Apabetalone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instytut Kardiologii" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Instytut Kardiologii". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Instytut Kardiologii, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Instytut Kardiologii, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Instytut Kardiologii has several departments that took part in Clinical trials: "The Cardinal Stefan Wyszyński Institute of Cardiology" - 10 trials, "Institute Of Cardiology" - 50 trials, "Institute of Cardiology, II Dept. of Coronary Heart Disease" - 5 trials, "Instytut of Kardiologii & Transplantology" - 3 trials, "I Klinika Choroby Wiencowej" - 2 trials